ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

PHXM PHAXIAM Therapeutics SA

3.10
0.00 (0.00%)
05 6월(6) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
PHAXIAM Therapeutics SA PHXM 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 3.10 09:00:00
개장가 저가 고가 종가 전일 종가
3.10 3.10
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
11/03/202421:31EDGAR2Form 15F-12B - Securities registration termination of..
11/03/202415:00GLOBEPHAXIAM Therapeutics announces effectiveness of voluntary..
06/03/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
05/03/202406:28EDGAR2Form S-8 POS - Securities to be offered to employees in..
05/03/202406:09EDGAR2Form POS AM - Post-Effective amendments for registration..
21/02/202420:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/02/202406:05GLOBEPHAXIAM Therapeutics announces intention to voluntary delist..
20/01/202400:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/01/202406:05GLOBEPHAXIAM Therapeutics announces its cash position at the end..
16/11/202321:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202306:05GLOBEPHAXIAM Provides Business and Financial Update for the Third..
25/10/202322:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202305:05GLOBEPHAXIAM Therapeutics obtains authorizations to launch its..
24/10/202305:05GLOBETP ICAP Midcap initiates coverage of PHAXIAM Therapeutics..
11/10/202319:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/10/202320:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/09/202304:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/09/202321:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/09/202321:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/09/202321:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/09/202322:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/07/202305:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..